AXIM BIOTECHNOLOGI COM USD0.0001 (AXIM)

0.33
OTC Markets
Prev Close 0.30
Day Low/High 0.33 / 0.33
52 Wk Low/High 0.06 / 1.26
Exchange OTC Markets
Shares Outstanding 39.76B
Market Cap 11.93M
Div & Yield N.A. (N.A)

AXIM Biotechnologies, Inc. Increases CanChew Cannabidiol (CBD) Gum Donations By 200%, Beneficiaries Include U.S. Veterans And Legacy Customers

AXIM® Launches Appreciation Program That Benefits U.S. Warfighters, Emphasizes Freedom to Choose Hemp Based Health and Wellness Options, Rewards Long-Term Consumer Use

AXIM Biotech Begins Human Clinical Trials With Cannabigerol (CBG) For Psoriasis And Eczema In Patients

AXIM's CBG Clinical Trials Led by World-Renowned Dermatologist and Specialist on Psoriasis and Eczema, Dr. Meinardi, at The Maurits Clinics in The Hague, The Netherlands

AXIM Biotech CEO Appointed To American Pain Association Board Of Advisors, Addresses American Opioid Abuse Epidemic

AXIM CEO Joins APA Board of Advisors in Appeal to U.S. Surgeon General About the No. 1 U.S. Health Crisis: Prescription Opioid Abuse Epidemic

AXIM Biotechnologies Expands Executive Team And Advisory Board With Finance And Pro Sports Leaders: Seth Yakatan And Marvin Washington

Hemp Industry Innovator, AXIM(R) Biotech, Adds Two Industry Leaders to the Company's Advisory Board: Seth Yakatan - Biotech Finance Consultant; and Marvin Washington - NFL Star and Sports Advisor

AXIM Biotechnologies Secures Land Down Payment For Hemp Life Sciences Manufacturing Site

Company's Global Manufacturing Facility Move Forward in Almere, The Netherlands

Photo Release -- AXIM Biotechnologies Adds Health Industry Senior Marketing Executive Joe Grace To Advisory Board

Veteran Marketing Executive Who Grew WebMD's Audience to 25 Million Unique Monthly Visitors Brings Decades of Health Industry Experience to AXIM Biotech's Board of Advisors

AXIM Biotech Explains Cannabis Chewing Gum Clinical Trials For Pain And Spasticity With MS, Plans To Enter General Pain Market

Agricultural Hemp Biotech's Cannabinoid Innovations for Multiple Sclerosis Patients Lead to Entry Into $60 Billion General Pain Market

AXIM Biotech Announces Launch Of Clinical Trials On MedChew RX(TM) And Development Of Pharmaceutical-Grade Cannabis Chewing Gum

Global Industrial Hemp Bioscience Company Announces Clinical Trials at Free University of Amsterdam, The Netherlands

AXIM Biotech Presents Patented Cannabinoid Delivery Methods At My Compassion's Chicago Cannabis Conference

Global Hemp Biotech Company Fosters Cannabinoid Education With Patients, Peers and the Public

Photo Release -- AXIM Biotechnologies, Inc. Supports Adopt-A-Soldier Platoon's Warfighter Independence Weekend

Award-Winning Patented Cannabinoid Release Gum, CanChew(R), Donated in Support of U.S. Service Members at July 4th Weekend Event

Photo Release -- AXIM Biotech CEO Addresses Cannabinoid Delivery Innovations At My Compassion's Cannabis Conference Chicago

Renowned Doctors Educate Patients, Peers and Public at Largest Midwest Cannabis Health Education Conference July 23-25 at Chicago's Navy Pier

Photo Release -- AXIM Biotech Announces Hemp Innovations For Life Sciences

Global Industrial Hemp Bioscience Company Announces Entry Into Food and Pharmaceutical Markets

Photo Release -- AXIM Biotech CEO Honored By Adopt-A-Soldier Platoon

Industrial Hemp Biosciences Leader Recognized for Service Through Generous Donations of Award-Winning Hemp-Infused Chewing Gum Donation to U.S. Service Members

Photo Release -- AXIM Biotech's New Website Commissioned To Award Winning Artist Andre Weinfeld

Industrial Hemp Biotech's Mission Conveyed Through the Eyes of Renowned Director and Artist

Photo Release -- AXIM Biotech Secures Exclusive License Agreement To Patented Cannabidiol (CBD) Gum

CBD Hemp Oil Chewing Gum Provides Discrete Option for Hemp Consumers Worldwide

Photo Release -- AXIM Biotech Garners Global Headlines After Announcing First-Ever Lines Of Cannabigerol (CBG) Products

Industrial Hemp Biotech Company Develops Everyday-Use Cannabigerol (CBG) Products

Photo Release -- Dr. Jacques F. Meis, World-Renowned Infectious Disease Specialist, Joins AXIM Biotechnologies, Inc.'s Advisory Board

Global Industrial Hemp Biosciences Leader Furthers Mission of Addressing Infectious Diseases Through Advances in Cannabinoid-Based Product Development

Photo Release -- AXIM Biotech Unveils World's First Hemp Cannabigerol (CBG) Oral Care & Cosmetic Products

Global Hemp Biotech Company Gains Global News Coverage on New Cannabigerol (CBG)-Based Products Soon to Be Available Worldwide

AXIM Biotechnologies, Inc. Announces Cosmetics Division

Industrial Hemp Biotech Company Leads Industry With Cannabinoid-Containing Cosmetics for Daily Use

AXIM Biotechnologies, Inc. Announces Hemp-Based Oral Care Division

Industry-Leading Commercial Hemp Biotechnology Company Developing First-of-Its-Kind Cannabinoid-Based Oral Care Daily Use Products

Photo Release: Dr. Murad A. Sunalp, Internationally Recognized Ophthalmology Expert, Joins AXIM Biotechnologies Advisory Board

Leading Industrial Hemp Biosciences Company Sets Sites on Furthering Ophthalmology-Focused Cannabinoid Research and Development, Expands R&D Portfolio With Cannabinoid-Based Ophthalmological Products

Photo Release: AXIM Biotechnologies Adds World Leaders In Cannabis Research And International Finance To Advisory Board

Dr. Arno Hazekamp and Warren C. Hutchins Join AXIM Biotechnologies' Initiative to Pioneer Global Industrial Hemp Pharmaceutical, Nutraceutical, Cosmeceutical, and Clean Energy Markets

Photo Release: AXIM Biotechnologies Announces Netherlands Land Deal For Manufacturing Site

Company's Global Innovative Hemp-Based Products Manufacturing Facility Planned in Almere, The Netherlands

Photo Release -- Top Global Experts Join AXIM Biotechnologies Advisory Board

'Invaluable Experience' Set to Bolster Company's Proposed Clinical Trials and Product Development

AXIM Biotechnologies Delivers Net Negative Carbon Footprint With All-Natural Industrial Hemp

Company's Proprietary Industrial Hemp Development, Production, and Delivery Methods Innovate Global Nutraceutical and Pharmaceutical Markets